Actively Recruiting
Chinese PE Multimodality Imaging Artificial Intelligence Study
Led by China-Japan Friendship Hospital · Updated on 2024-08-28
1500
Participants Needed
1
Research Sites
939 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The CHinese pulmOnary Embolism Multimodality Imaging-artifiCial intelligencE Study (CHOICE) is a prospective observational multi-center study that will collect imaging text data and raw data of patients with pulmonary embolism (PE) in China. By combining artificial intelligence technology, it aims to identify imaging markers to assist in early diagnosis, differential diagnosis, risk stratification, and prognosis assessment of PE.
CONDITIONS
Official Title
Chinese PE Multimodality Imaging Artificial Intelligence Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 14 years and older
- Patients suspected of pulmonary embolism (PE)
You will not qualify if you...
- Pregnant women
- Refuse to follow up
- Incomplete or discontinued imaging scans
- Insufficient quality of image data to allow for analysis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
China-Japan Frendship hospital
Beijing, China, 100029
Actively Recruiting
Research Team
M
Min Liu, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here